EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan

Sabeen Shah iD, Nyashadzaishe Mafirakureva, Adam Trickey, Aliya Hasnain iD, Uzma Khan iD, Saira Khowaja, Hiba Ashraf, Naila Baig-Ansari iD, Matthew Hickman, Peter Vickerman iD, Josephine G Walker, Aaron G Lim iD

Journal of Viral Hepatitis · 2026-04 · 33 (4)

DOI: 10.1111/jvh.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 12.03.2026. Verfasst von Sabeen Shah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Directorate, Indus Hospital & Health Network, Karachi, Pakistan. Hauptthemen laut MEDLINE: Antiviral Agents, Tertiary Care Centers, Primary Health Care, Hepatitis C, Chronic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bristol, Wellcome Trust, NIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) endemic regions require accessible treatment interventions. Effectiveness and costs of a pilot HCV treatment programme were evaluated at an embedded primary care service within a tertiary care centre at Indus Hospital and Health Network in Karachi, Pakistan. Data on patients ( n = 1288, median age 40 years) initiating direct‐acting antiviral (DAA) treatment (October 2016 to December 2018) were extracted from hospital records. Eligible patients had chronic HCV, were treatment naïve, and without hepatic decompensation. Multivariable logistic regression analysed factors associated with treatment outcomes (not completing treatment, treatment completion without sustained virological response test at 12 weeks (SVR12) visit, and treatment completion with SVR12). Costs (2019 USD) were estimated using micro‐costing from financial records and staff interviews. Among 1288 patients (63% women), 93% (1200/1288) completed treatment, and 74% (884/1200) attended SVR12 visit, with 98% ( n = 870/884) cured. Compared with 0–29 year‐olds, incomplete treatment was lower among 30–49 year‐olds (aOR 0.47 [0.26–0.83]) and ≥ 50 year‐olds (aOR 0.48 [0.24–0.93]). SVR12 non‐attendance was higher for 24‐week versus 12‐week regimens (aOR: 3.46 [1.51–7.93]), but lower for patients with APRI scores 0.5–1.49 (aOR 0.69 [0.50–0.96]) and ≥ 1.5 (aOR 0.44 [0.24–0.78]) compared to 0–0.49. The mean treatment cost was $370.74 per patient, driven by clinic visits $271.80 (73.3%), labs $68.32 (18.4%), and DAAs $30.62 (8.3%). Overall, a high treatment completion and cure rate were achieved, with a low average cost per patient, indicating that this HCV treatment model can be affordable and may be considered for widescale treatment scale‐up in Pakistan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsTertiary Care CentersPrimary Health CareHepatitis C, ChronicHumansPakistanFemaleMaleAdultMiddle AgedTreatment OutcomeSustained Virologic ResponseYoung AdultAdolescentChildChild, PreschoolInfantHepacivirusInfant, NewbornAged

Stichwörter der Autor:innen

direct‐acting antiviral treatmenthepatitis C virusloss to follow‐uplow middle income countries

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Global Health Directorate, Indus Hospital & Health Network, Karachi, Pakistan.
  • Department of Family Medicine, Aga Khan University, Karachi, Pakistan.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Health Economics and Decision Science, School of Health & Related Research, University of Sheffield, Sheffield, UK.
  • Department of Medicine, Aga Khan University, Karachi, Pakistan.
  • Interactive Research and Development (IRD) Global, Singapore, Singapore.

ORCID-Profile: Sabeen Shah, Aliya Hasnain, Uzma Khan, Naila Baig-Ansari, Peter Vickerman, Aaron G Lim

Förderung

  • University of Bristol
  • Wellcome Trust
  • NIHR
  • Research England
  • National Institute for Health and Care Research

Zitieren

APA

Shah, S., Mafirakureva, N., Trickey, A., Hasnain, A., Khan, U., Khowaja, S., Ashraf, H., Baig-Ansari, N., Hickman, M., Vickerman, P., Walker, J. G., & Lim, A. G. (2026). Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan. Journal of Viral Hepatitis, 33(4). https://doi.org/10.1111/jvh.70164

Vancouver

Shah S, Mafirakureva N, Trickey A, Hasnain A, Khan U, Khowaja S, et al. Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan. Journal of Viral Hepatitis. 2026;33(4). doi:10.1111/jvh.70164

BibTeX
@article{Shah2026,
  author = {Shah, Sabeen and Mafirakureva, Nyashadzaishe and Trickey, Adam and Hasnain, Aliya and Khan, Uzma and Khowaja, Saira and Ashraf, Hiba and Baig-Ansari, Naila and Hickman, Matthew and Vickerman, Peter and Walker, Josephine G and Lim, Aaron G},
  title = {Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {4},
  doi = {10.1111/jvh.70164}
}
Kostenlos starten →